Bristol-Myers Squibb
BMY
$44.78
Share price
-0.16%
Change (1 day)
-32.93%
Change (1 year)
Categories
Bristol-Myers Squibb (BMY) - Total debt
Total debt on the balance sheet as of March 2024 : $57.40 B
According to Bristol-Myers Squibb's latest financial reports the company's total debt is $57.40 B. A company’s total debt is the sum of all current and non-current debts.
Bristol-Myers Squibb - Total debt on balance sheet (from 2001 to 2024)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $41.46 B | 1.83% |
| 2022-12-31 | $40.71 B | -10.7% |
| 2021-12-31 | $45.59 B | -11.76% |
| 2020-12-31 | $51.67 B | 8.7% |
| 2019-12-31 | $47.53 B | 546.86% |
| 2018-12-31 | $7.34 B | -7.7% |
| 2017-12-31 | $7.96 B | 18.69% |
| 2016-12-31 | $6.70 B | 0.28% |
| 2015-12-31 | $6.68 B | -14.59% |
| 2014-12-31 | $7.83 B | -6.09% |
| 2013-12-31 | $8.34 B | 12.79% |
| 2012-12-31 | $7.39 B | 34.66% |
| 2011-12-31 | $5.49 B | 0.84% |
| 2010-12-31 | $5.44 B | -14.4% |
| 2009-12-31 | $6.36 B | -5.61% |
| 2008-12-31 | $6.73 B | 7.45% |
| 2007-12-31 | $6.27 B | -15.64% |
| 2006-12-31 | $7.43 B | -13.5% |
| 2005-12-31 | $8.59 B | -16.92% |
| 2004-12-31 | $10.34 B | 18.19% |
| 2003-12-31 | $8.75 B | 14.58% |
| 2002-12-31 | $7.64 B | 19.17% |
| 2001-12-31 | $6.41 B |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $29.33 B | -48.91% | 🇺🇸 USA |
 Novartis NVS | $27.28 B | -52.47% | 🇨🇭 Switzerland |
 Pfizer PFE | $70.84 B | 23.40% | 🇺🇸 USA |
 AbbVie ABBV | $59.38 B | 3.44% | 🇺🇸 USA |
 Eli Lilly LLY | $25.22 B | -56.06% | 🇺🇸 USA |
 Amgen AMGN | $64.61 B | 12.55% | 🇺🇸 USA |
 Sanofi SNY | $20.36 B | -64.52% | 🇫🇷 France |
 Biogen BIIB | $6.94 B | -87.90% | 🇺🇸 USA |
 Merck MRK | $35.05 B | -38.94% | 🇺🇸 USA |
 AstraZeneca AZN | $34.55 B | -39.82% | 🇬🇧 UK |